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The enzyme porphobilinogen deaminase (PBGD; hydroxy-
methylbilane synthase; EC 2.5.1.61) catalyses an early step of
the tetrapyrrole-biosynthesis pathway in which four molecules
of the monopyrrole porphobilinogen are condensed to form
a linear tetrapyrrole. The enzyme possesses a dipyrromethane
cofactor, which is covalently linked by a thioether bridge to an
invariant cysteine residue (Cys241 in the Bacillus megaterium
enzyme). The cofactor is extended during the reaction by the
sequential addition of the four substrate molecules, which
are released as a linear tetrapyrrole product. Expression in
Escherichia coli of a His-tagged form of B. megaterium PBGD
has permitted the X-ray analysis of the enzyme from this
species at high resolution, showing that the cofactor becomes
progressively oxidized to the dipyrromethene and dipyrro-
methanone forms. In previously solved PBGD structures, the
oxidized cofactor is in the dipyromethenone form, in which
both pyrrole rings are approximately coplanar. In contrast, the
oxidized cofactor in the B. megaterium enzyme appears to be
in the dipyrromethanone form, in which the C atom at the
bridging -position of the outer pyrrole ring is very clearly in a
tetrahedral configuration. It is suggested that the pink colour
of the freshly purified protein is owing to the presence of the
dipyrromethene form of the cofactor which, in the structure
reported here, adopts the same conformation as the fully
reduced dipyrromethane form.
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1. Introduction
Tetrapyrroles such as haem and chlorophyll play vital
physiological roles in respiration and photosynthesis (Warren
& Smith, 2009). One of the early steps in the biosynthesis of
tetrapyrroles is catalysed by the enzyme porphobilinogen
deaminase (PBGD), which is also known as hydroxy-
methylbilane synthase (EC 2.5.1.61). This enzyme catalyses
the polymerization of four molecules of the monopyrrole
porphobilinogen in a stepwise head-to-tail manner to form the
linear tetrapyrrole preuroporphyrinogen or hydroxymethyl-
bilane (Fig. 1; Jordan, 1991). PBGDs are monomeric enzymes
with molecular masses in the range 34–44 kDa depending on
the species. The enzymes in this family exhibit high thermal
stabilities and have pH optima in the range 8.0–8.5, with
isoelectric points between 4.0 and 4.5. It has been shown that
ring A of the tetrapyrrole product (Fig. 1) is the first to bind
to the enzyme, followed by rings B, C and finally D (Jordan,
1991). The enzyme possesses a dipyrromethane cofactor
(Fig. 2) that is covalently bound to the enzyme by a thioether
linkage involving an invariant cysteine residue (Cys241 in the
Bacillus megaterium enzyme; Jordan & Warren, 1987; Warren
& Jordan, 1988; Scott et al., 1988). Whilst the cofactor can be
assembled slowly from two molecules of porphobilinogen, it
can be generated more quickly by cleavage of the product,
preuroporphyrinogen, which reacts rapidly with the apo-
enzyme (Scott et al., 1989; Awan et al., 1997). During catalysis,
the free -position of the cofactor acts as the attachment point
to which the growing tetrapyrrole chain is anchored. The four
porphobilinogen substrate molecules (S) react sequentially
with the enzyme (E) to generate stable ES1, ES2, ES3 and ES4
complexes. ES4 is therefore an enzyme-bound hexapyrrole,
representing two pyrroles of the cofactor attached to the
tetrapyrrole bilin product. After the assembly of ES4, cleavage
of the link between the cofactor and the first substrate
molecule completes the reaction, allowing the tetrapyrrole
product to be released.
The X-ray structures of the Escherichia coli, human and
Arabidopsis enzymes have been solved (Louie et al., 1992,
1996; Ha¨dener et al., 1999; Gill et al., 2009; Song et al., 2009;
Roberts et al., 2013). The polypeptide is folded into three
domains (1–3), each of approximately the same size. The
topology of domains 1 and 2 shows a strong resemblance to
the type II periplasmic binding proteins (Louie et al., 1992;
Louie, 1993), whereas domain 3 has an entirely distinct fold.
The dipyrromethane cofactor is covalently attached to a
cysteine residue in a loop of domain 3 so that it is positioned
within a deep active-site cleft formed between domains 1 and
2. The active-site cleft is formed by several crucial arginine
residues that bind the side-chain carboxylates of the cofactor
and/or substrate. Indeed, many of the point mutations in the
human PBGD gene which give rise to the disease acute
intermittent porphyria affect these conserved arginine resi-
dues (Wood et al., 1995).
B. megaterium, literally meaning ‘big beast’ (Vary, 1994), is a
common Gram-positive soil bacterium that is highly versatile
as its metabolism allows it to utilize inexpensive carbon
sources and is capable of surviving in a divergent range
of environments (Vary et al., 2007). It has many commercial
applications in food processing and in the biotechnological
production of various drugs and vitamins, including the
tetrapyrrole-derived vitamin B12 (Bunk et al., 2010). The gene
for PBGD in B. megaterium encodes a protein of 310 amino
acids which has 48% sequence identity to the E. coli enzyme.
Here, we report the structure analysis of PBGD from
B. megaterium in a crystal form that diffracts synchrotron
radiation to 1.5 A˚ resolution. The collection of data from two
crystals, which were flash-cooled at periods of 40 and 50 d
after purification, demonstrates that the dipyrromethane
cofactor adopts two conformations corresponding to partially
oxidized states. One of these is likely to be the dipyrro-
methene form, as it adopts essentially the same conformation
as the fully reduced dipyrromethane. The other is likely to be
the further oxidized dipyrromethanone form, which has not
previously been observed structurally. This form possesses a
tetrahedral ring-linking -C atom in the terminal pyrrole,
and the two structures presented here demonstrate that the
proportion of the cofactor in this state increases as a function
of time, with a concomitant decrease in the amount of the
other conformer.
2. Methods
The expression of B. megaterium PBGD in E. coli using a
pET-14b construct has been reported recently along with the
purification and crystallization of the enzyme (Azim et al.,
2013). The affinity-purified enzyme was assayed spectro-
photometrically using the method described in Shoolingin-
Jordan et al. (1997). Since the dipyrromethane cofactor of
PBGD is light-sensitive, crystals were grown in the dark using
the hanging-drop method. Crystals of the enzyme could be
obtained reproducibly in 0.1M sodium cacodylate pH 6.5–6.8,
0.2 Mmagnesium acetate, 25–30% PEG 8K following removal
of the polyhistidine tag and concentration of the enzyme to
2.5 mg ml1. Selected crystals were treated by the addition of
glycerol to approximately 30%(v/v) before mounting in loops
and flash-cooling with an Oxford Cryosystems cryocooler.
Data were collected from two crystals, one of which (crystal 1)
was cooled approximately 40 d after purification of the protein
and the other of which (crystal 2) was cooled when the protein
was approximately 50 d old.
X-ray data collection on crystal 1 was undertaken at station
I03 at the Diamond Light Source (DLS; Didcot, England)
using a Pilatus 6M-F detector at a wavelength of 0.976 A˚. Data
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Figure 1
The reaction catalysed by porphobilinogen deaminase. Four molecules
of the pyrrole porphobilinogen are condensed to form the linear
tetrapyrrole preuroporphyrinogen (hydroxymethylbilane). The acetic
acid and propionic acid side chains of each pyrrole are abbreviated A and
P, respectively, and the four rings of the tetrapyrrole product are indicated
in italics as A, B, C and D.
Figure 2
The dipyrromethane cofactor of porphobilinogen deaminase is covalently
attached to the enzyme by a thioether bond to a cysteine residue. Four
substrate pyrroles are added linearly to the cofactor; finally, hydrolysis
of the linkage between the substrate and the cofactor releases the
tetrapyrrole product hydroxymethylbilane.
were collected from crystal 2 on the European Synchrotron
Radiation Facility (ESRF) beamline BM14 using a MAR
Mosaic 225 CCD detector at a wavelength of 1.07 A˚. Both
data sets were collected at a temperature of 100 K using 1
oscillations and were processed with MOSFLM (Leslie, 2006;
Powell et al., 2013), SCALA (Evans, 2006) and other programs
from the CCP4 suite (Winn et al., 2011). Structure analysis
was successful for the crystal 1 data set using the molecular-
replacement program MOLREP (Vagin & Teplyakov, 2010)
with E. coli PBGD (48% identity; PDB entry 1pda; Louie et
al., 1992) as the search model. Refinement and rebuilding of
the B. megaterium PBGD structure was completed using this
data set with the programs REFMAC (Murshudov et al., 2011)
and Coot (Emsley & Cowtan, 2004). Subsequently, the struc-
ture was refined as above using the crystal 2 data set, and
further crystallographic details for both structures can be
found in Table 1. The geometric restraints for refinement of
the two forms of the cofactor were generated using PRODRG
(Schu¨ttelkopf & van Aalten, 2004). The final refined structures
and reflection data sets were analysed by the validation
programs PROCHECK (Laskowski et al., 1993), SFCHECK
(Vaguine et al., 1999) and RAMPAGE (Lovell et al., 2003;
Chen et al., 2010) and have been deposited in the Protein Data
Bank (http://www.wwpdb.org) with accession codes 4mlv and
4mlq for crystals 1 and 2, respectively. Figures of the structures
were prepared using CueMol (http://www.cuemol.org/en) and
were rendered using POV-Ray (http://www.povray.org).
3. Results
3.1. Structure analysis
The structure of B. megaterium PBGD has been determined
at a resolution of 1.46 A˚, with an R factor of 14.1% and an
Rfree of 18.6% (see Table 1). The resulting model of the
enzyme was found to have 99% of the amino acids within the
favoured regions of the Ramachandran plot and the remaining
1% within allowed areas according to the RAMPAGE criteria
(Lovell et al., 2003). The estimated r.m.s. coordinate error
(Read, 1986) of 0.11 A˚ suggests that the structure is defined
with high accuracy. In addition, the structure of the enzyme in
which the cofactor has undergone more extensive oxidation is
presented at the slightly lower resolution of 1.6 A˚ with similar
refinement and validation statistics (see Table 1). The overall
fold of the enzyme is shown in Fig. 3, in which the secondary-
structure elements are labelled according to the notation of
Louie et al. (1992).
All enzymes in this family adopt a three-domain fold in
which domains 1 and 2 resemble the fold of type II periplasmic
binding proteins and the third domain, to which the cofactor
is covalently attached, adopts a distinct + topology. Starting
at the N-terminal end, the backbone of B. megaterium PBGD
follows that of the E. coli enzyme until the end of stand 21,
where there is a substantial disordered region extending from
residues 42 to 62. This disordered region is known to form a
flexible loop covering the active site and has only been defined
structurally in the Arabidopsis enzyme (Roberts et al., 2013).
The ordered region of the B. megaterium structure resumes at
residue 63, which is at the N-terminal end of helix 21, and
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Table 1
Data-collection and processing statistics for B. megaterium porphobili-
nogen deaminase.
Values in parentheses are for the outer resolution shell.
Data set Crystal 1 Crystal 2
Beamline I03, DLS BM14, ESRF
Wavelength (A˚) 0.976 1.072
Space group P212121 P212121
Unit-cell parameters (A˚)
a 53.32 53.01
b 65.78 65.12
c 97.21 96.78
Mosaic spread () 0.26 1.01
Resolution (A˚) 48.60–1.46
(1.53–1.46)
31.33–1.60
(1.69–1.60)
Rmerge† (%) 6.1 (55.9) 8.8 (149.3)
CC1/2‡ (%) 99.8 (86.7) 99.8 (33.1)
Rmeas§ (%) 6.7 (61.3) 9.5 (168.4)
Completeness (%) 100.0 (100.0) 95.6 (88.7)
Average I/(I) 14.4 (3.0) 10.1 (0.9)
Multiplicity 6.2 (6.0) 6.4 (4.5)
No. of observed reflections 378329 (52575) 273058 (25347)
No. of unique reflections 60772 (8748) 42866 (5649)
Wilson plot B factor (A˚2) 15.8 17.0
R factor (%) 14.1 16.1
Free R factor (%) 18.6 24.2
R.m.s.d., bond lengths (A˚) 0.024 0.019
R.m.s.d., bond angles () 2.44 2.14
No. of reflections in working set 57626 40552
Mean protein B factor (A˚2) 24.6 28.2
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ CC1/2 is the half-set correla-
tion coefficient as described by Karplus & Diederichs (2012). § Rmeas =
P
hklfNðhklÞ=
½NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the mean
intensity of the N(hkl) observations Ii(hkl) of each unique reflection hkl after scaling.
Figure 3
The tertiary structure of B. megaterium PBGD at 1.46 A˚ resolution
showing the oxidized form of the dipyrromethane cofactor covalently
attached to Cys241. The domains of the enzyme are numbered 1–3 and
the secondary-structure elements are labelled according to the nomen-
clature of Louie et al. (1992).
continues to follow the fold of the E. coli enzyme closely, with
the exception of a few single-residue insertions in loop regions
that are distant from the active site. The sequence alignment
shown in Fig. 4 shows the marked similarity of enzymes in this
family. Not surprisingly, the eukaryotic enzymes exhibit some
significant differences from the prokaryotic PBGDs, e.g. the
human enzyme has a large insertion towards the C-terminal
end and the Arabidopsis enzyme appears to be somewhat
truncated relative to the others at the same end of the mole-
cule.
The refined structure of B. megaterium PBGD super-
imposes with the E. coli and Arabidopsis enzymes (which are
of comparable resolution) with r.m.s. C deviations of 1.05
and 1.02 A˚ for 280 and 271 structurally equivalent residues,
respectively. Likewise, superposition with the structure of
the human enzyme demonstrates a similarly good r.m.s.d. of
1.13 A˚ for 276 structurally equivalent C atoms. It has been
suggested that the domains of this
enzyme may move independently
to allow substantial rearrange-
ments of the polypyrrole during
the elongation cycle (Louie et al.,
1992, 1996). Inspection of the
A. thaliana PBGD structure
suggested that domains 2 and 3 of
the enzyme appear to move as a
relatively rigid unit with respect
to domain 1 (Roberts et al., 2013).
Indeed, the superpositions of
B. megaterium PBGD with the
E. coli, Arabidopsis and human
enzymes which are shown in Fig. 5
corroborate this suggestion and
demonstrate that the rigid body
formed of domains 2 and 3 of the
B. megaterium enzyme has a very
similar orientation to that of the
E. coli enzyme, with which it
shares 48% sequence identity.
Indeed, the domain shifts of the
B. megaterium and E. coli
enzymes seem to lie between the
larger movements exhibited by
the Arabidopsis and human
PBGDs (Fig. 5), which have
slightly lower sequence identities
of 43 and 47% to the B. mega-
terium enzyme, respectively.
3.2. Definition of the cofactor
redox states
In the electron-density maps
for both structures presented
here, the dipyrromethane
cofactor, which is covalently
attached to Cys241, is very well
defined (Fig. 6). The two rings of the cofactor (labelled C1 and
C2) are held within a large highly conserved cleft between
domains 1 and 2 of the protein. The cleft has a preponderance
of basic residues, most notably arginine, which interact elec-
trostatically with the carboxylate side groups of the pyrroles.
At the base of the cleft, an invariant aspartic acid, Asp82 in
B. megaterium PBGD, forms hydrogen bonds to both the C1
and C2 pyrrole-ring N atoms. These interactions have been
described in great detail elsewhere for high-resolution struc-
tures of related enzymes (e.g. Louie et al., 1992, 1996; Roberts
et al., 2013), and the high degree of conservation of these
critical amino acids (see Fig. 4) means that essentially the same
interactions are observed in the B. megaterium structure
reported here. However, one interesting difference is that the
flap covering the active site of B. megaterium PBGD (residues
42–62) completely lacks electron density, despite many efforts
to rebuild it during refinement of the two structures reported
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Figure 4
Sequence alignment and secondary structure of B. megaterium PBGD. An alignment of B. megaterium
PBGD with the enzyme from another prokaryote (E. coli) along with the plant (A. thaliana) and human
enzymes. The secondary-structure elements are labelled using the notation of Louie et al. (1992) and the
amino-acid residues are colour-coded as follows: cyan, basic; red, acidic; green, neutral polar; pink, bulky
hydrophobic; white, Gly, Ala and Pro; yellow, Cys.
here. This suggests that the active-site flap of B. megaterium
PBGD is rather more disordered than in the structures of
other related enzymes. It is not immediately obvious why this
should be the case since the flap sequence is quite highly
conserved in PBGD enzymes (Fig. 4), although one factor may
be the complete absence of crystal contacts in this region of
the B. megaterium structure. In principle, the greater flexibility
of the flap may confer the cofactor of the B. megaterium
enzyme with greater flexibility and sensitivity to environ-
mental factors such as pH, ionic strength and redox state.
Indeed, reducing SDS–PAGE and mass spectrometry
confirmed that cleavage of the enzyme occurs over a period
of several days during storage on ice, giving a reduction in
its molecular mass from 35 to 28 kDa. This is consistent with
cleavage by trace proteases somewhere within the highly
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Figure 5
Superposition of B. megaterium PBGD with the Arabidopsis, E. coli
and human enzymes. (a) The overall least-squares superposition of
B. megaterium PBGD (cyan) with the E. coli enzyme (yellow) as well as
the Arabidopsis and human enzymes (green and pink, respectively). A
superposition of the four enzymes based on domain 1 alone is shown in
(b), which emphasizes the different concerted shifts of domains 2 and 3
relative to domain 1 in the enzyme from each species.
Figure 6
Electron density showing the dual conformations of the cofactor. The
local fold of the protein is indicated as a cyan tube and the side chains
adjacent to the cofactor are shown in the same colour as the enzyme,
while the cofactor itself is coloured green. The map obtained for the
40-day-old protein is shown in (a), with that for the 50-day-old protein
shown in (b); both maps are contoured at 0.7 r.m.s.. The C2 ring clearly
adopts two positions depending on its oxidation state, which are shown as
C2(ox) and C2(red). In the oxidized conformation, the C2 ring possesses
a carbonyl O atom substituted at the -position; accordingly, the
proportion of cofactor adopting this conformer increases with time.
disordered active-site flap region between residues 42 and 62
during storage. It may be interesting that kinetic studies of the
enzyme showed that whilst it has a kcat that is comparable to
those of other PBGDs (0.1 s1), its Km of 100 mM is rather
high for this enzyme family (Jordan, 1991), although it is
comparable to the values found for algal PBGDs (Battersby
et al., 1983). Hence, it is conceivable that a lower affinity for
substrate may originate from greater disorder in the active-site
flap region of the enzyme.
Another interesting feature of B. megaterium PBGD is the
pink colouration which is found in the cells expressing the
enzyme and in the final affinity-purified enzyme (Azim et al.,
2013). Over time the protein solution becomes progressively
yellow and the crystals we obtained were indeed of this colour,
as is the case for most PBGDs studied to date. Prior to
structure analysis of the B. megaterium enzyme, we anticipated
that the initial pink coloration might indicate the presence of
a previously unseen polypyrrole intermediate or an unusual
oxidation product of the dipyrromethane cofactor. Structural
studies of the E. coli and A. thaliana PBGD enzymes have
shown that the cofactor becomes
oxidized to the predominantly
planar dipyrromethenone form,
in which the -position of the
terminal pyrrole ring (ring C2) is
oxidized, as shown in Fig. 7. This
form of the enzyme is catalyti-
cally inactive owing to the usual
attachment site for incoming
pyrroles being blocked by a
carbonyl O atom: an effect that
probably accounts for the slow
inactivation of the enzyme over
2–3 weeks during storage or
crystallization.
In both of the structures of
B. megaterium PBGD that we
report here, the C2 ring clearly
adopts two positions (Fig. 6), one
of which corresponds to the fully
reduced dipyrromethane that has
been observed in structures of the
E. coli and human enzymes when
they are crystallized under redu-
cing conditions (Ha¨dener et al.,
1999; Song et al., 2009). The other
position of the C2 ring corre-
sponds approximately to that of
the oxidized cofactor in the high-
resolution structures of the E. coli
and Arabidopsis enzymes when
the crystals were grown under
oxidizing conditions (Louie et al.,
1996; Roberts et al., 2013). In
these structures, the C2 ring of
the cofactor has a carbonyl
oxygen substituent at the -posi-
tion (see Fig. 7a), which will render the enzyme inactive (see
above). In the dipyrromethenone state, both rings of the
cofactor are found to be approximately coplanar and,
although they are not constrained to be so by the molecular
geometry, this effect may facilitate the delocalization of elec-
trons over both pyrrole rings. In the B. megaterium enzyme the
electron-density map clearly shows that the oxidized confor-
mation of the cofactor has the same oxygen substituent in the
C2 ring, which is suggestive of the same dipyromethenone
form. However, the other -position of the C2 ring which
partakes in the methylene bridge with the adjacent C1 pyrrole
is clearly tetrahedral, in contrast to the trigonal planar
configuration that is found in dipyrromethenone. This suggests
that in the B. megaterium PBGD structure the ‘oxidized’
conformation of the cofactor is actually the partly reduced
dipyrromethanone form, the formula for which is shown in
Fig. 7(a). Accordingly, refinement of the occupancies of the
oxidized and reduced states in the two structures reported
here showed that the proportion of the oxidized dipyrro-
methanone form increases in a time-dependent manner from
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Figure 7
Oxidation states of the dipyrromethane cofactor. Different possible oxidation states of the dipyrromethane
cofactor are shown in (a) along with a proposed mechanism for oxidation of the dipyrromethane to
dipyrromethene and subsequently dipyrromethanone (b).
30% in the case of the 40-day-old protein to 50% for the
50-day-old protein.
As mentioned above, the intriguing pink colouration of
the freshly purified protein gradually changes to yellow over
a 2–3-week period. One possibility is that the pink colour is
owing to the dipyrromethene state (Fig. 7), which is derived
from the fully reduced cofactor dipyrromethane by partial
oxidation. Since the protonated dipyrromethene has a positive
charge delocalized over two conjugated rings, one therefore
might expect it to be more intensely coloured than the other
intermediates shown in Fig. 7. In an electron-density map, a
dipyrromethene would be expected to look exactly like the
fully reduced dipyrromethane because it only differs from the
latter by the loss of an H atom from the bridging C atom. The
yellow colour that accumulates over time could therefore be
owing to the dipyrromethanone (as shown in Fig. 7), which
arises from further oxidation of the dipyrromethene. A
proposed mechanism for this process is shown in Fig. 7(b).
To summarize, the native enzyme is most likely to contain a
dipyrromethane, which oxidizes to a dipyrromethene with an
extended chromophore giving the red-shifted spectrum. In a
time-dependent fashion, the dipyrromethene is converted into
the yellow dipyrromethanone form. The latter conversion, as
shown in Fig. 7(b), merely requires the addition of water to
the protonated Schiff base followed by prototropic rearran-
gements. According to this mechanism, the dipyrromethenone
is the further oxidation product of the dipyrromethanone.
The two structures reported here superimpose very closely,
with an r.m.s.d. of only 0.17 A˚ for all C atoms. Since analysis
of the A. thaliana PBGD structure suggested that domains 2
and 3 appeared to move slightly relative to domain 1 of the
enzyme as a rigid unit (Roberts et al., 2013), the same analysis
was conducted for both of the B. megaterium structures.
Interestingly, domains 2 and 3 appear to rotate towards
domain 1 by approximately 0.6 in the more oxidized struc-
ture, suggesting that as the proportion of cofactor in the more
extended state increases, the active site of the enzyme is able
to close more. This rigid-body rotation gives rise to move-
ments of several loops over the active site of at most 0.5 A˚.
Whilst this domain movement would appear to be consistent
with the more extended conformation of the oxidized
cofactor, allowing the active-site cleft to close, it should be
noted that the scale of the loop movements is of the order of
the differences in unit-cell parameters. Thus, whether these
domain movements are a cause or an effect of the slightly
different crystal lattice parameters cannot easily be deter-
mined.
4. Discussion
Porphobilinogen deaminase is an intriguing enzyme and few
details of how it catalyses the tetrapolymerization of pyrroles
are well understood, although a number of possible models for
the elongation process have been suggested (Jordan, 1991;
Louie et al., 1992). One possibility is that domain movements
cause the bound cofactor and polypyrrole intermediates to
move past the catalytic centre of the enzyme in a stepwise
manner, thus permitting the binding of additional substrate
moieties and the completion of the tetrapyrrole product. This
model would allow the condensation reactions to be driven
by the extensive interactions that we observe between the
enzyme and the cofactor, coupled with acid–base catalysis
provided by the invariant aspartate residue (Asp82 in the
PBGD from B. megaterium). Whilst the reported structure
confirms all of these features, it is unusual in that the enzyme
has a highly disordered flap over the active site, with some 20
amino-acid residues being invisible in the electron density.
One consequence of this is that the full extent of the cavities
around the active-site crevice becomes apparent and hints at
the numerous possibilities for accommodating the polypyrrole
intermediates of the elongation reaction. Another model of
the elongation reaction is that the cofactor remains close to
the positions observed in the X-ray structure as an incoming
pyrrole is condensed with it. If the newly added pyrrole can
then be repositioned, this local movement may be sufficient to
‘free-up’ the catalytic apparatus for the next elongation cycle.
In the reduced conformation, the C2 ring of the cofactor is
buried further within the active-site cavity, which creates more
space for an incoming pyrrole to bind in the vicinity of the
catalytic aspartate without displacement of the cofactor.
However, the tight geometric constraints of the active site
are such that steric hindrance between the cofactor and an
incoming pyrrole would probably force the C2 ring into a
conformation in which its free -position would be even less
accessible to the incoming substrate. Regardless of the
mechanism of elongation, movement of the cofactor is most
likely to be linked to movement of the protein domains, and
the current structure provides further corroboration for a
model in which domains 2 and 3 of the protein appear to move
relative to domain 1 as a fairly rigid unit (Roberts et al., 2013).
In this respect, it is interesting that domains 2 and 3 provide
the bulk of the binding interactions with the cofactor, whilst
domain 1 provides the main catalytic residue of the enzyme,
Asp82.
PBGD enzymes are highly sensitive to oxidation of the
dipyrromethane cofactor, which causes the protein to become
notably yellow with time (Jordan, 1991; Louie et al., 1996).
Intriguingly, the B. megaterium enzyme has a pronounced pink
colour during overexpression and purification (Azim et al.,
2103), although the purified protein slowly becomes yellow
over a period of a few weeks. Our structural analyses of the
B. megaterium enzyme at two different time points after
purification establish the different oxidation states of the
cofactor that are likely to be responsible for these effects. The
native enzyme will only be active with fully reduced dipyrro-
methane at the active site. However, the more exposed nature
of the active-site cleft in this enzyme when compared with
other PBGD structures suggests that the cofactor may be
particularly prone to oxidation to the dipyrromethene form,
which is highly conjugated and is likely to have a red-shifted
spectrum when protonated. Protonation of the dipyrro-
methene gives it a positive charge on one of the pyrrole N
atoms which can readily be stabilized by its close proximity to
the catalytic aspartate Asp82. Whilst discrimination between
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dipyrromethene and dipyrromethane would not be possible
by X-ray diffraction analysis at the resolutions reported here,
there are compelling reasons to believe that the pink
colouration is owing to the presence of the partly oxidized
protonated dipyrromethene form. Addition of water to this
dipyrrin converts it to the yellow dipyrromethanone form,
which possesses a tetrahedral -C atom in the terminal
pyrrole. The time-dependent accumulation of this inter-
mediate is confirmed by our X-ray analyses. Further oxidation
of the dipyrromethanone will ultimately lead to the dipyrro-
methenone form, which has been confirmed in other high-
resolution PBGD structures (Louie et al., 1996; Roberts et al.,
2013). The loss of catalytic activity as the cofactor is oxidized
to the dipyrromethanone form cannot be reversed by the
addition of mild reducing agents. Indeed, there is no known
reducing agent that will reverse the oxidized cofactor to its
original redox state in a predictable fashion and still maintain
the integrity of the protein structure.
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